NCT06964841

Brief Summary

742 / 5.000 A 57-year-old male: Denies chronic degenerative, allergic, traumatic, transfusional, or surgical complications. He denies a family history of testicular cancer or abnormalities in testicular descent. The patient presented with an enlarged right testicle that had been present for 1 month. He saw his family doctor, who prescribed antibiotic and analgesic treatment, without improvement, and was referred to our service. Upon examination, the right testicle was palpable, nontender, slightly enlarged, indurated, with nodulations measuring 0.5 cm in diameter, and free spermatozoa. The left testicle was normal. He underwent radical orchiectomy, which revealed renal testicular lymphoma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 28, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 29, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 1, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 9, 2025

Completed
Last Updated

May 9, 2025

Status Verified

May 1, 2025

Enrollment Period

3 months

First QC Date

May 1, 2025

Last Update Submit

May 1, 2025

Conditions

Testicular Lymphoma

Keywords

testislymphomanodalstomach

Outcome Measures

Primary Outcomes (1)

  • Mortality

    Describe the mortality in primary testicular lymphoma

    3 months

Eligibility Criteria

Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

57 year old male with testicular lymphoma

You may qualify if:

  • Patient with testicular lymphoma

You may not qualify if:

  • Patient without testicular lymphoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Mexicano del Seguro Social

Mérida, Yucatán, Mexico

Location

Related Publications (1)

  • Motyckova M, Vosahlova V, Belada D, Simkovic M, Zak P. [Primary testicular lymphoma]. Vnitr Lek. 2017 Summer;63(6):415-422. Czech.

    PMID: 28840738BACKGROUND

MeSH Terms

Conditions

Lymphoma

Condition Hierarchy (Ancestors)

Neoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PHD

Study Record Dates

First Submitted

May 1, 2025

First Posted

May 9, 2025

Study Start

January 1, 2025

Primary Completion

March 28, 2025

Study Completion

March 29, 2025

Last Updated

May 9, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

anyone who ask via e-mail

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
anytime
Access Criteria
e-mail

Locations

ME(1)